Livestock News

FDA approves drug to reduce ammonia gas emissions in cattle


With recent debate circulating about the carbon footprint left from livestock, Elanco decided to create an alternative. Elanco Animal Health Inc. announced that a first-of-its-kind, medicated feed article, Experior (Lubabegron), was granted approval by the Food and Drug Administration Center for Veterinary Medicine. It was approved for the reduction of ammonia gas emissions per pound of live weight and hot carcass weight in cattle during the last 14 to 91 days on feed.

The FDA’s news release on the approval can be viewed here.

“Elanco is proud of this pioneering effort to address key customer needs to help reduce environmental impact,” said Aaron Schacht, executive vice president, Innovation, Regulatory and Business Development of Elanco Animal Health. “This innovation is an important new tool that should enable beef producers to care for their cattle and the environment.”

Elanco is committed to providing One Health-focused innovations — such as Experior — that support the industry’s environmental sustainability efforts.*

We recognize the impact animal health has on the health of people and the planet. One Health is the ecosystem in which healthy animals, healthy people and a healthy environment work in balance for a healthier world, and is the lens through which Elanco views innovation. To achieve a future where everyone can live and thrive, science must make progress on three aspects of global health: healthy animals, people, and planet. Elanco believes it starts with animals.

*Ammonia gas emissions were measured for individual animals or small groups of animals held in environmentally controlled facilities. Based on existing information, reliable predictions of the reduction of ammonia gas emissions cannot be made on a herd, farm, or larger scale.

Sponsored Content on AGDaily
Any views or opinions expressed in this article are those of the author and do not reflect those of AGDAILY. Comments on this article reflect the sole opinions of their writers.